Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03956342 · ClinicalTrials.gov registry record
ClinRO Sedation Validation
A clinical trial, sponsored by Duke University.
- Completed
- Registry status
- 35
- Enrollment target
NCT03956342: Completed study, sponsored by Duke University.
NCT03956342 is a clinical trial that has completed, run by Duke University. The registered enrollment target is 35 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03956342 has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- 35 participants
- Enrollment target
Study Summary
This study will conduct qualitative interviews to provide evidence for the content validity and comprehension of existing physician-reported measures of sedation levels of children receiving anesthesia to facilitate a diagnostic or surgical procedure. Information gained from this study will inform the use of the measure in studies that are part of the PTN.
Primary Outcome
A 1 hour qualitative interview will be completed and coded to assess the quality of the measures being assessed.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 35 participants |
| Start Date | 2019-04-15 |
| Est. Completion | 2019-11-15 |
What the finished NCT03956342 record still lists
NCT03956342 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 35 participants, a relatively small participant target.
The record links to 0 conditions, and to 0 interventions.
NCT03956342 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03956342 about?
NCT03956342 is a clinical study titled "ClinRO Sedation Validation". This study will conduct qualitative interviews to provide evidence for the content validity and comprehension of existing physician-reported measures of sedation levels of children receiving anesthesia to facilitate a diagnostic or surgical procedure. Information gained from this study will inform t...
What is the current status of trial NCT03956342?
This trial is currently completed. The enrollment target is 35 participants. The study started on 2019-04-15. Estimated completion is 2019-11-15.
Who is sponsoring clinical trial NCT03956342?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT01697371 · 35 participants · NA
Proton Therapy in the Treatment of Liver Metastases
- NCT01940757 · 35 participants · Phase 1
Experimental Infection of Hookworm-naïve Adults With Dermally-applied Infectious Necator Americanus Hookworm Larvae
- NCT02235857 · 35 participants · NA
Post Approval Study of Liposorber LA-15 System for the Treatment of Focal Segmental Glomerulosclerosis in Children
- NCT02637934 · 35 participants · Phase 1
Phase I Pilot Study of Biodistribution, Metabolism and Excretion of Novel Radiotracer [18F]Fluorthanatrace (FTT) by PET/CT
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI